Doxycycline Hyclate Tablet, Delayed Release
Product Images NDC 62332-482

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Doxycycline Hyclate (NDC 62332-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxycycline-full-150mg Tablet.jpg (Doxycycline Full 150mg Tablet)

Illustration showing the doxycycline hyclate 243 tablet from three perspectives: top view displaying the imprint '243', side view of the tablet shape, and a full tablet side view held between thumbs and index fingers demonstrating size and thickness.*

FDA Label Image

60tablets (Doxycycline Hyclate Dr Tablets mg100)

Label for Doxycycline Hyclate Delayed-Release Tablets, USP 100 mg by Alembic Pharmaceuticals Inc. The oral tablet packaging contains 60 tablets with a clear note of prescription use only. The label includes storage and handling instructions, manufacturer details, and a barcode.*

FDA Label Image

60tablets (Doxycycline Hyclate Dr Tablets mg150)

The packaging label for Doxycycline Hyclate Delayed-Release Tablets, USP shows a 150 mg strength in oral tablet form. The label indicates this is a human prescription drug with 60 tablets per container. The manufacturer is Alembic Pharmaceuticals Inc. The label includes storage instructions, dosage information references, and a barcode with NDC 62332-483-60.*

FDA Label Image

60tablets (Doxycycline Hyclate Dr Tablets mg200)

Label for Doxycycline Hyclate Delayed-Release Tablets, USP 200 mg, oral tablets by Alembic Pharmaceuticals Inc. The label includes dosage strength, quantity of 60 tablets, storage instructions, manufacturing details, NDC 62332-484-60, and barcode with lot and expiration information.*

FDA Label Image

60tablets (Doxycycline Hyclate Dr Tablets mg75)

Label for Doxycycline Hyclate Delayed-Release Tablets, USP 75 mg by Alembic Pharmaceuticals Inc. The label states the dosage form as delayed-release tablets in a 60-tablet package. It includes storage instructions, the NDC number 62332-481-60, and warnings not to chew or crush the tablets. Manufacturer information is also present.*

FDA Label Image

Doxycycline-one-third Tablet.jpg (Doxycycline One Third Tablet)

An illustration showing the top and side views of a small, square tablet. Additionally, the diagram depicts a hand holding one tablet between the thumb and index finger to provide size perspective. The tablet is part of Doxycycline Hyclate delayed-release oral tablets by Alembic Pharmaceuticals Inc.*

FDA Label Image

Doxycycline-structure.jpg (Doxycycline Structure)

Chemical structure diagram of doxycycline hyclate showing its molecular backbone and functional groups.*

FDA Label Image

Doxycycline-two-third Tablet.jpg (Doxycycline Two Third Tablet)

Illustration showing the top and side views of a Doxycycline Hyclate delayed-release tablet with the imprint '24.' The diagram also depicts the tablet being held between the thumbs and index fingers to demonstrate proper handling, highlighting the tablet shape and size.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.